241
Participants
Start Date
August 31, 2002
Primary Completion Date
February 28, 2003
Study Completion Date
February 28, 2003
10 mg HC-ER
Single dose
20 mg HC-ER
Single dose
30 mg HC-ER
Single dose
40 mg HC-ER
Single dose
10 mg HC / 325 mg APAP
Single dose
Matching Placebo
Single dose
Zogenix, Inc.
INDUSTRY